Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Severe psychiatric disorders such as schizophrenia, bipolar disorder and major depressive disorder are brain diseases of unknown origin. No biological marker has been documented at the pathological, cellular, or molecular level, suggesting that a number of complex but subtle changes underlie these illnesses. We have used proteomic technology to survey postmortem tissue to identify changes linked to the various diseases. Proteomics uses two-dimensional gel electrophoresis and mass spectrometric sequencing of proteins to allow the comparison of subsets of expressed proteins among a large number of samples. This form of analysis was combined with a multivariate statistical model to study changes in protein levels in 89 frontal cortices obtained postmortem from individuals with schizophrenia, bipolar disorder, major depressive disorder, and non-psychiatric controls. We identified eight protein species that display disease-specific alterations in level in the frontal cortex. Six show decreases compared with the non-psychiatric controls for one or more diseases. Four of these are forms of glial fibrillary acidic protein (GFAP), one is dihydropyrimidinase-related protein 2, and the sixth is ubiquinone cytochrome c reductase core protein 1. Two spots, carbonic anhydrase 1 and fructose biphosphate aldolase C, show increase in one or more diseases compared to controls. Proteomic analysis may identify novel pathogenic mechanisms of human neuropsychiatric diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most of these used glial fibrillary acidic protein (GFAP) as a marker for astrocytes, and reported that GFAP, or GFAPpositive cells were decreased in mood-disordered subjects relative to controls (Johnston-Wilson et al, 2000;Si et al, 2004;Rajkowska and Miguel-Hidalgo, 2007).”
From Neurocircuitry of Mood Disorders (2010) · cites this paper as Johnston-Wilson et al, 2000
In the citing paper
“In the frontal cortex one study found that four forms of the astrocytic product, glial fibrillary acidic protein (GFAP), were decreased in mood-disordered subjects relative to controls, although it was not determined whether this decrement reflected a reduction in the astrocyte density or the GFAP expression (Johnston-Wilson et al. 2000).”
From Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression (2008) · cites this paper as Johnston-Wilson et al. 2000
Citations
Cites
High resolution two-dimensional electrophoresis of proteins.
O'Farrell, P. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41496-8 · Cited by 19,246
Shevchenko, A., Jensen, O. N., Podtelejnikov, A. V., Sagliocco, F., Wilm, M., Vorm, O., Mortensen, P., Shevchenko, A., Boucherie, H., & Mann, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14440 · Cited by 1,427
Eng, L. F., & Ghirnikar, R. S. (1994) · Brain Pathology · doi:10.1111/j.1750-3639.1994.tb00838.x · Cited by 864
Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33
Goshima, Y., Nakamura, F., Strittmatter, P., & Strittmatter, S. M. (1995) · Nature · doi:10.1038/376509a0 · Cited by 706
Quantitative aspects of reactive gliosis: A review
Norton, W. T., Aquino, D. A., Hozumi, I., Chiu, F. C., & Brosnan, C. F. (1992) · Neurochemical Research · doi:10.1007/bf00993263 · Cited by 549
Modulation of pH by neuronal activity
Chesler, M., & Kaila, K. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90191-a · Cited by 531
A Family of Rat CRMP Genes Is Differentially Expressed in the Nervous System
Wang, L.-H., & Strittmatter, S. M. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-19-06197.1996 · Cited by 347
A CYTOCHEMICAL STUDY OF THE LOCALIZATION OF CARBONIC ANHYDRASE IN THE NERVOUS SYSTEM
Giacobini, E. (1962) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1962.tb11859.x · Cited by 235
Hamajima, N., Matsuda, K., Sakata, S., Tamaki, N., Sasaki, M., & Nonaka, M. (1996) · Gene · doi:10.1016/s0378-1119(96)00445-3 · Cited by 208
Perrone-Bizzozero, N. I., Sower, A. C., Bird, E. D., Benowitz, L. I., Ivins, K. J., & Neve, R. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14182 · Cited by 206
Rinaman, L., Card, J., & Enquist, L. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00685.1993 · Cited by 187
Glial Fibrillary Acidic Protein: Dynamic Property and Regulation by Phosphorylation
Inagaki, M., IMakamura, Y., Takeda, M., Nishimura, T., & Inagaki, N. (1994) · Brain Pathology · doi:10.1111/j.1750-3639.1994.tb00839.x · Cited by 157
Inagaki, M., Gonda, Y., Nishizawa, K., Kitamura, S., Sato, C., Ando, S., Tanabe, K., Kikuchi, K., Tsuiki, S., & Nishi, Y. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39622-x · Cited by 154
Levi, G., Patrizio, M., Bernardo, A., Petrucci, T. C., & Agresti, C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1541 · Cited by 148
Johnston, N. L., Cerevnak, J., Shore, A. D., Torrey, E. F., & Yolken, R. H. (1997) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(97)00115-5 · Cited by 142
Self-citationRoussel, G., Delaunoy, J., Nussbaum, J. L., & Mandel, P. (1979) · Brain Research · doi:10.1016/0006-8993(79)90599-7 · Cited by 126
In vivo neurogenesis is inhibited by neutralizing antibodies to basic fibroblast growth factor
Tao, Y., Black, I. B., & DiCicco-Bloom, E. M. (1997) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(199709)33:3<289::aid-neu7>3.0.co;2-y · Cited by 112
Creatine Kinase and Aldolase in Serum: Abnormality Common to Acute Psychoses
Meltzer, H. Y. (1968) · Science · doi:10.1126/science.159.3821.1368 · Cited by 106
Edgar, P. F., Schönberger, S. J., Dean, B., et al. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000463 · Cited by 79
Goshima, Y., Kawakami, T., Hori, H., Sugiyama, Y., Takasawa, S., Hashimoto, Y., Kagoshima-Maezono, M., Takenaka, T., Misu, Y., & Strittmatter, S. M. (1997) · Journal of Neurobiology · Cited by 74
HIV-1 Envelope gp120 Alters Astrocytes in Human Brain Cultures
Pulliam, L., West, D., Haigwood, N. L., et al. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.439 · Cited by 70
Anderson, N. L., Anderson, N. L., Esquer‐Blasco, R., et al. (1995) · Electrophoresis · doi:10.1002/elps.11501601324 · Cited by 66
James, P. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.6045 · Cited by 63
Tardy, M., Fages, C., Prince, G. L., Rolland, B., & Nunez, J. (1990) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-5876-4_4 · Cited by 59
Cerebrospinal fluid protein variations in common to Alzheimer's disease and schizophrenia.
Johnson, G. S., Brane, D., Block, W., van Kammen, D. P., Gurklis, J. A., Peters, J. L., Wyatt, R. J., Kirch, D., Ghanbari, H. A., & Merril, C. R. (1992) · PubMed · Cited by 53
Laping, N. J., Nichols, N. R., Day, J. R., Johnson, S. A., & Finch, C. E. (1994) · Endocrinology · doi:10.1210/endo.135.5.7956913 · Cited by 52
Dihydropyrimidinase deficiency presenting in infancy with severe developmental delay
Henderson, M. J., Ward, K., Simmonds, H. A., Duley, J. A., & Davies, P. M. (1993) · Journal of Inherited Metabolic Disease · doi:10.1007/bf00711685 · Cited by 51
Neuronal and Glial Gene Expression in Neocortex of Downʼs Syndrome and Alzheimerʼs Disease
Goodison, K. L., Parhad, I. M., White, C. L., Sima, A. A. F., & Clark, A. W. (1993) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199305000-00002 · Cited by 43
Differences in cerebrospinal fluid proteins between patients with schizophrenia and normal persons.
Harrington, M. G., Merril, C. R., & Torrey, Ε. F. (1985) · Clinical Chemistry · doi:10.1093/clinchem/31.5.722 · Cited by 42
Wildenauer, D. B., Körschenhausen, D. A., Hoechtlen, W., Ackenheil, M., Kehl, M., & Lottspeich, F. (1991) · Electrophoresis · doi:10.1002/elps.1150120706 · Cited by 41
Mulcrone, J. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(94)00040-f · Cited by 40
Acetazolamide in Bipolar Affective Disorders
Hayes, S. (1994) · Annals of Clinical Psychiatry · doi:10.3109/10401239409148987 · Cited by 39
Comings, D. E. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.4.798 · Cited by 37
Fujita, K., Yamauchi, M., Matsui, T., Titani, K., Takahashi, H., Kato, T., Isomura, G., Ando, M., & Nagata, Y. (1998) · Brain Research · doi:10.1016/s0006-8993(97)00612-4 · Cited by 37
Dihydropyrimidinase Deficiency, a Progressive Neurological Disorder?
Putman, C., Rotteveel, J. J., Wevers, R. A., Gennip, A. H., Bakkeren, J. A. J. M., & ABREU, R. A. D. (1997) · Neuropediatrics · doi:10.1055/s-2007-973681 · Cited by 35
Murphy, G. M., Lee, Y. L., Jia, X., Yu, A. C., Majewska, A. K., Song, Y., Schmidt, K., & Eng, L. F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65062716.x · Cited by 35
Bigbee, J. W., & Eng, L. F. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb10863.x · Cited by 34
Kennedy, P. G. E., Major, E. O., Williams, R. K., & Straus, S. E. (1994) · Virology · doi:10.1006/viro.1994.1679 · Cited by 25
Meltzer, H. Y. (1970) · Journal of Psychiatric Research · doi:10.1016/0022-3956(70)90019-1 · Cited by 22
Immunoreactive Aldolase C in Cerebrospinal Fluid of Patients with Neurological Disorders
WILLSON, V. J. C., Graham, J. G., McQueen, I. N., & Thompson, R. J. (1980) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456328001700302 · Cited by 22
Pol, S., Bousquet-Lemercier, B., Pavé-Preux, M., et al. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81017-9 · Cited by 21
Serum creatine kinase, aldolase, and copper in acute and chronic schizophrenics.
Coffey, J. W., Heath, R. G., & Guschwan, A. (1970) · PubMed · Cited by 20
Ishida, K., Kaneko, K., Kubota, T., Itoh, Y., Miyatake, T., Matsushita, M., & Yamada, M. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00108-1 · Cited by 17
Meltzer, H. Y., Grinspoon, L., & Shader, R. I. (1970) · Comprehensive Psychiatry · doi:10.1016/0010-440x(70)90018-0 · Cited by 16
Use of Two-dimensional Electrophoretic Protein Maps in Studies of Schizophrenia
Merril, C. R., & Harrington, M. G. (1988) · Schizophrenia Bulletin · doi:10.1093/schbul/14.2.249 · Cited by 5
Cited by
Drevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241
“…four forms of the astrocytic product, glial fibrillary acidic protein (GFAP), were decreased in mood-disordered subjects relative to controls, although it was not determined whether this decrement reflected a reduction in the astrocyte density or the GFAP expression (Johnston-Wilson et al. 2000).”
BackgroundNeurocircuitry of Mood Disorders
Price, J. L., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.104 · Cited by 1,606
Middeldorp, J., & Hol, E. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.005 · Cited by 1,080
The tripartite synapse: roles for gliotransmission in health and disease
Halassa, M. M., Fellin, T., & Haydon, P. G. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.12.005 · Cited by 852
Epigenomic Profiling Reveals DNA-Methylation Changes Associated with Major Psychosis
Mill, J., Tang, T., Kaminsky, Z., Khare, T., Yazdanpanah, S., Bouchard, L., Jia, P., Assadzadeh, A., Flanagan, J., Schumacher, A., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.01.008 · Cited by 773
Metadata
- Authors
- Johnston-Wilson, N. L., Sims, C. D., Hofmann, J.-P., Anderson, L., Shore, A. D., Torrey, E. F., Yolken, R. H., & the Stanley Neuropathology Consortium
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Johnston-Wilson, N L
- ORCID
- Shore, A D
- Venue
- Molecular Psychiatry
- Published
- 2000-03-01
- Volume
- 5
- Issue
- 2
- Pages
- 142-149
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2328048826
- Cited by
- 531
- References
- 45
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 17 · 2023: 14 · 2022: 12 · 2021: 27 · 2020: 19 · 2019: 14 · 2018: 22 · 2017: 16 · 2016: 29 · 2015: 27 · 2014: 29 · 2013: 22 · 2012: 27
- FWCI
- 9.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- schizophrenia, bipolar disorder, major depressive disorder, frontal cortex, brain proteins, postmortem brain, proteomics, glial fibrillary acidic protein, carbonic anhydrase I, biomarkers
- MeSH terms
- Collapsin Response Mediator Protein 1, Amino Acid Sequence, Autopsy, Bipolar Disorder, Carbonic Anhydrases, Depressive Disorder, Frontal Lobe, Fructose-Bisphosphate Aldolase, Glial Fibrillary Acidic Protein, Humans, Image Processing, Computer-Assisted, Molecular Sequence Data, Nerve Tissue Proteins, Peptide Fragments, Reference Values, Schizophrenia, Electron Transport Complex III, Electrophoresis, Gel, Two-Dimensional
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.